tradingkey.logo
tradingkey.logo
Suchen

Intelligent Bio Solutions Inc

INBS
Zur Watchlist hinzufügen
2.240USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
4.48MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Intelligent Bio Solutions Inc Unternehmen

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc Informationen

BörsenkürzelINBS
Name des UnternehmensIntelligent Bio Solutions Inc
IPO-datumDec 23, 2020
CEOSimeonidis (Harry)
Anzahl der mitarbeiter16
WertpapierartOrdinary Share
GeschäftsjahresendeDec 23
Addresse135 W 41St St,
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl10036
Telefon16467905756
Websitehttps://ibs.inc/
BörsenkürzelINBS
IPO-datumDec 23, 2020
CEOSimeonidis (Harry)

Führungskräfte von Intelligent Bio Solutions Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Intelligent Bio Solutions Inc?

Die fünf größten Anteilseigner von Intelligent Bio Solutions Inc sind: Mr. Harry Simeonidis

Wie viele Institutionen halten Anteile an Intelligent Bio Solutions Inc (INBS)?

Mit Stand vom 2026Q1 halten 29 Institutionen Anteile an Intelligent Bio Solutions Inc, mit einem Gesamtmarktwert von etwa 1.95K, was 0.09% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -189189.00 gestiegen.